Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 3: New Opportunities in Epigenetic Therapies

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Introduction
Guowei Fang
AbbVie, Inc., North Chicago, IL, United States
from AACR Annual Meeting 2015 on April 18, 2015 1:00 PM-3:00 PM
Chemical probes for epigenetic proteins
Paul Brennan
University of Oxford, Oxford, United Kingdom
from AACR Annual Meeting 2015 on April 18, 2015 1:00 PM-3:00 PM
Discovering chemical probes of histone methyltransferases
H. Ümit Kaniskan
Icahn School of Medicine at Mt. Sinai, New York, NY, United States
from AACR Annual Meeting 2015 on April 18, 2015 1:00 PM-3:00 PM
Discovery of EPZ015666: A first-In-class PRMT5 inhibitor with potent in vitroand in vivo activity
Kenneth W. Duncan
Epizyme, Inc., Cambridge, MA, United States
from AACR Annual Meeting 2015 on April 18, 2015 1:00 PM-3:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4